Donor Specific Antibody
Showing 1 - 25 of >10,000
Subclass of Donor-specific Antibody asRisk Factor of Antibody
Active, not recruiting
- Antibody-mediated Rejection
-
Montpellier, Hérault, FranceCHU Lapeyronie
Jan 18, 2023
Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy
Active, not recruiting
- Kidney Transplant Rejection
- +2 more
- Kidney allograft biopsy depending on donor-derived cell-free DNA levels
-
Berlin, GermanyCharité-Universitätsmedizin
Jul 22, 2022
Cell-Free Nucleic Acids Trial (Cell free DNA analysis)
Not yet recruiting
- Cell-Free Nucleic Acids
- Cell free DNA analysis
- (no location specified)
Jan 27, 2022
Expanding Scope of Post-transplant HLA-specific Antibody
Not yet recruiting
- Kidney Transplant
- +7 more
- cf-DNA
- +2 more
-
Liverpool, Merseyside, United KingdomLiverpool University Hospitals NHS Foundation Trust
Aug 29, 2023
Donor Specific B Cells and Antibody Mediated Rejection
Terminated
- Sensitized Kidney Transplant Recipients
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Dec 13, 2021
Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)
Active, not recruiting
- Antibody-mediated Rejection
- +5 more
-
Los Angeles, CaliforniaNorko Ammerman
Mar 25, 2022
Lung Transplant Recipient, Donor Specific Antibodies, Antibody Mediated Rejection Trial in France (bronchoscopy.)
Recruiting
- Lung Transplant Recipient
- +2 more
- bronchoscopy.
-
Le Plessis Robinson, France
- +4 more
Feb 11, 2022
Kidney Transplant Trial in Suwan (Mycophenolate mofetil 500mg Tab. or 250mg Cap., Tacrolimus, Methylprednisolone/prednisolone)
Active, not recruiting
- Kidney Transplant
- Mycophenolate mofetil 500mg Tab. or 250mg Cap.
- +3 more
-
Suwan, Korea, Republic ofAjou University Hospital
Jul 6, 2021
Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)
Active, not recruiting
- Kidney Failure, Chronic
- +6 more
-
Los Angeles, CaliforniaNorko Ammerman
Mar 25, 2022
Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)
Completed
- Renal Transplant
- Rituximab
- intravenous immune globulin
-
Seoul, Korea, Republic of
- +1 more
Oct 25, 2022
Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)
Recruiting
- Kidney Transplantation
- TCD601
-
San Francisco, California
- +4 more
Oct 28, 2022
Donor-Specific Antibodies in Immunized Living Donor Kidney
Completed
- Renal Failure
- (no location specified)
Jun 28, 2022
Donor-Derived Cell-Free DNA With Tocilizumab Treatment for
Active, not recruiting
- Rejection Chronic Renal
- Kidney Transplant Rejection
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 18, 2022
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2-Negative Breast Carcinoma
- Biospecimen Collection
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 30, 2023
Nanoparticle for DSA Removal
Recruiting
- Kidney Failure
- Presence of Donor Specific Antibodies
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich, Division of Anaesthesiology
Mar 11, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)
Active, not recruiting
- Renal Failure
- Enriched Hematopoietic Stem Cell Infusion
-
Chicago, Illinois
- +1 more
Jul 15, 2022
Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)
Recruiting
- Adenovirus Infection
- Adenovirus Specific T lymphocytes
-
Columbus, OhioNationwide Children's Hospital
Sep 1, 2022
Renal Failure Trial in Chicago (Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion)
No longer available
- Renal Failure
- Biological/Vaccine: Enriched Hematopoetic Stem Cell Infusion
-
Chicago, IllinoisNorthwestern Memorial Hospital
Jul 15, 2022
Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)
Active, not recruiting
- Kidney Failure
- Enriched Hematopoietic Stem Cell Infusion
-
Chicago, Illinois
- +1 more
Jul 15, 2022
Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)
Recruiting
- Allogeneic Stem Cell Transplant
- +2 more
- Viral specific VST Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 15, 2022
Intrathecal Synthesis Index of Specific Antitreponema IgG for
Completed
- Neurosyphilis
- Measure of an antibody index for intrathecal synthesis of specific anti-Treponema pallidum IgG by ELISA.
-
Geneva, SwitzerlandLaurence Toutous Trellu
Nov 21, 2023
Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)
Withdrawn
- Leukemia
- Stem Cell Transplantation
-
Munich, Bavaria, Germany3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022
ddcfDNA in Kidney Transplant Recipients
Recruiting
- Kidney Transplant Rejection
- AlloSeq cfDNA
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 22, 2023
Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs Trial in Madrid (Food-specific
Recruiting
- Immunoglobulin E-Mediated Food Allergy
- +3 more
- Food-specific Immunoglobulin G4 and/or Immunoglobulin E antibody reactions
-
Madrid, SpainUniversidad Politécnica de Madrid
Jan 3, 2023